Search - tctmd.com

Displaying 41 - 60 of 60

Sort: Relevancy | Date

Presentation NY Valves 2024

DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience

Presenter: Anita W. Asgar

June 06, 2024

Presentation NY Valves 2024

Case Presentation III: High Risk Mitral VIV for LVOTO

Presenter: Shmuel Chen

June 06, 2024

Presentation NY Valves 2024

TAVR in Bicuspid Mega-Annulus and Critical AS

Presenter: Vivek Patel

June 05, 2024

Podcast TCTMD Talking Points

The VIVA Trial

May 15, 2024

News Conference News EHRA 2024

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

Todd Neale

April 16, 2024

Presentation Fellows 2024

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Presenter: Vivian G. Ng

April 13, 2024

News Conference News EHRA 2024

Some Degree of Hemolysis Seen in Nearly All Pulsed-Field Ablation Cases

Todd Neale

April 09, 2024

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Presenter: Eduardo Rame

March 06, 2024

Presentation THT 2024

In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Presenter: Antoon van den Enden

March 05, 2024

Presentation THT 2024

Case 4: TMVR VIV With a Surprise

Presenter: Jeffrey Heslop

March 05, 2024

Presentation THT Abstracts 2024

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Presenter: Vivek Jha

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT 2024

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

News Daily News

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Shelley Wood

February 19, 2024

Presentation Miami Valves 2024

Structural Heart Disease and Treatment

Presenter: Vivian Avila

February 03, 2024

Presentation Miami Valves 2024

A Novel Technique of Prosthetic Leaflet Modification to Enable ViV TMVR

Presenter: Nikolaos Spilias

February 01, 2024

Conference VIVA 2024

VIVA 2024

Las Vegas, Nevada

November 03, 2024

November 06, 2024

CME

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

CME

Advertisement

DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience

Case Presentation III: High Risk Mitral VIV for LVOTO

TAVR in Bicuspid Mega-Annulus and Critical AS

The VIVA Trial

Good Early Results for Conformable, ‘Single-Shot’ Pulsed-Field Ablation Catheter

LAA Closure, PFO Closure, and Other Novel Structural Heart Procedures

Some Degree of Hemolysis Seen in Nearly All Pulsed-Field Ablation Cases

Ex Vivo Gene Therapy in Cardiac Allografts

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

In-vivo Pressure-Volume Reconstructions to Evaluate Immediate Changes in Left Ventricular Cardiomechanics Following Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis

Case 4: TMVR VIV With a Surprise

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Early Feasibility Study of the Vivasure PerQseal® Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

Structural Heart Disease and Treatment

A Novel Technique of Prosthetic Leaflet Modification to Enable ViV TMVR

VIVA 2024

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content